Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-13

Clinical Trial Update: Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of fimasartan for hypertension has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2018-02-13